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Abstract
The mitochondrial calcium uniporter is a highly selective calcium channel localized to the inner 
mitochondrial membrane. Here, we describe the structure of an MCU ortholog from the fungus 
Neosartorya fischeri (NfMCU) determined to 3.8 Å resolution by phase-plate cryo-electron 
microscopy. The channel is a homotetramer with two-fold symmetry in its amino terminal domain 
(NTD) that adopts a similar structure to that of human MCU. The NTD assembles as a dimer of 
dimer to form a tetrameric ring that connects to the transmembrane domain through an elongated 
coiled-coil domain. The ion conducting pore domain maintains four-fold symmetry with the 
selectivity filter positioned at the start of the pore forming TM2 helix. The aspartate and glutamate 
sidechains of the conserved DIME motif are oriented toward the central axis and separated by one 
helical turn. Thus, the structure of NfMCU offers new insights into channel assembly, selective 
calcium permeation, and inhibitor binding.
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Introduction
Mitochondria can take up large amounts of calcium from their environment, which can 
modulate ATP production, alter cytoplasmic Ca2+ dynamics, and trigger cell death1,2. 
Calcium enters the mitochondria matrix through the mitochondrial calcium uniporter, a 
highly selective calcium channel that is localized to the inner mitochondrial membrane3. In 
humans, the uniporter is a protein complex, or “uniplex”, consisting of at least four 
components: the ion conducting pore – MCU4,5, an essential membrane spanning subunit – 
EMRE6, and peripheral membrane gate-keeping proteins – MICU1 and MICU27,8. While 
MCU is found in all major eukaryotic taxa, EMRE is metazoan-specific and is required for 
the conductivity of MCU in these organisms6,9. On the contrary, the Dictyostelium MCU 
homolog, whose genome lacks EMRE, is sufficient to operate as a pore-forming channel10. 
Uniporter activity has diverged in fungi, even being lost entirely in certain lineages such as 
S. cerevisiae 11. In most fungi, the pore-forming MCU is the only component of the 
uniporter based on genome sequence analysis12 and likely represents the minimal channel 
component of the uniporter for calcium uptake. A recent study utilized functional 
mutagenesis to demonstrate that the MCU ortholog from the fungus Aspergillus fumigatus 
can mediate Ca2+ transport into mitochondria13.
Interestingly, MCU exhibits no discernible sequence homology to other cation channels12, 
making it difficult to predict structure and function using computational tools. Although the 
structures of various isolated MCU domains or the auxiliary component of the uniplex have 
been reported – the N-terminal domain (NTD) of human MCU14,15, the pore domain of an 
N-terminal deletion of the C. elegans MCU or cMCU-ΔNTD16, and human MICU117 – 
fundamental questions about the channel’s assembly, gating, and ion permeation remain 
unanswered. The recent NMR structure of the cMCU-ΔNTD revealed a pentameric channel 
pore with an occluded ion pathway and EMRE was suggested to be the key to driving the 
pore from being in the occluded to an open, ion conductive state16; however, there is no 
structural data on metazoan MCU and EMRE together. Mounting evidence for the 
pathophysiological relevance of the uniporter complex1,18 provides further impetus for 
structure determination of the intact channel. To address these longstanding questions, we 
determined the cryo-EM structure of an MCU homolog from Neosartorya fischeri, NfMCU, 
and also performed in-depth functional studies on this uncharacterized channel. The 
structure defines the architecture of the channel subunit of the MCU and sheds insights into 
channel assembly and function.
Biochemistry and structure determination
The architectural and functional complexity of metazoan MCU led us to take a reductionist 
approach and characterized MCU orthologs from fungi, whose genomes encode for only the 
ion conducting pore subunit12, with the goal of understanding basic principles governing 
channel assembly and function. Among those tested, the 488-residue wildtype MCU 
ortholog from Neosartorya fischeri, NfMCU, showed the best biochemical properties in 
terms of protein expression and stability and was modified for structural studies (see 
Methods). Unlike the pentameric cMCU-ΔNTD from the NMR study16, NfMCU purified as 
a tetramer in solution (Extended Data Fig. 1). Additionally, it confers uniporter function to 
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bacteria and NfMCU proteoliposomes recapitulate the voltage-dependent Ca2+ uptake 
property of the MCU19 (Methods and Extended Data Fig. 2).
Structure determination of NfMCU using single particle cryo-EM was technically 
challenging for the following reasons: small protein size of 180kDa for a channel tetramer, 
symmetry mismatch between the pore and soluble domains, and an elongated shape with 
minimal features. Also, detergent solubilized NfMCU aggregated when frozen and those in 
amphipols exhibited orientation bias. We first overcame the stability issue by reconstituting 
the channel into nanodiscs but, owing to the channel’s flexibility in nanodiscs, whose size is 
much larger than the transmembrane part of the channel, we could only determine the 
structure to ~15 Å resolution. This led us to consider using the newly developed scaffolding 
protein saposin for reconstitution (see Methods)20, which we rationalized could adapt its 
oligomerization to maintain NfMCU in an artificial lipid bilayer that is proportional to the 
channel’s smaller transmembrane domain. NfMCU reconstituted in saposin markedly 
improved the structure to an overall resolution of 4.6 Å; however, several parts of the 
channel were poorly resolved, likely due to inaccurate particle alignment stemming from the 
inherently low contrast of small particles. Finally, we used a Volta phase plate to image the 
NfMCU saposin complex, which ultimately allowed us to determine the structure to an 
overall resolution of 3.8 Å according to the gold-standard Fourier shell correlation 0.143 
criterion (Extended Data Fig. 3, Extended Data Table 1 and Methods).
Consistent with our biochemical analysis of NfMCU in detergent, the EM map 
unambiguously shows tetrameric assembly of NfMCU (Fig. 1a). The map was of sufficient 
quality for model building of major parts of the protein (Extended Data Fig. 4 and Methods). 
However, parts of the N- and C-termini as well as the long loop in the NTD were disordered 
and were not modeled in the final structure (Methods). The EM map also revealed clear 
electron density for the 81-residue saposin, which we modeled as poly-alanine (Extended 
Data Fig. 5). Six saposin molecules – each forming a C-shaped clamp oriented at a ~45° 
angle to the central axis – encircle the lipid bilayer to stabilize NfMCU. Thus, for the first 
time, our structure also reveals how saposin oligomerizes to maintain a membrane protein in 
lipid.
Overall architecture of NfMCU
NfMCU forms an elongated, three-tiered channel tetramer with each tier corresponding to a 
structural domain: the N-terminal domain (NTD), coiled coil domain (CCD) and 
transmembrane domain (TMD) (Fig. 1b and Extended Data Fig. 6). Although NfMCU is 
tetrameric, it transitions from being four-fold symmetric at the TMD to two-fold symmetric 
in the NTD, which forms a dimer of dimer (Fig. 1c, 2a). Unlike the NMR structure of 
cMCU-ΔNTD, which lacks the NTD and adopts a constricted architecture, NfMCU is 
architecturally open, with large fenestrations in the space defined by the CCD (Fig. 1b and 
Extended Data Fig. 7a). Sitting atop the NTD, the CCD resembles pillars supporting the 
TMD. The tight packing among the four NTD subunits, as well as the exceptionally long 
CC1 helix that extends into TM1, dictates the spacing among the four CCDs, thereby, 
creating a highly solvent accessible space below the ion conduction pathway.
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There are several major differences between the structure of NfMCU and cMCU-ΔNTD 
(Extended Data Fig. 7a, b). In addition to their oligomeric states and overall architecture, the 
secondary structural elements between the two structures are also quite different. The CC1 
and TM1 is a single extended helix in NfMCU but is five short, broken helices in cMCU-
ΔNTD (Extended Data Fig. 7b). These structural differences are unlikely to be caused by the 
different origins of the two channels, as the CCD, TMD and selectivity filter are highly 
conserved among MCU orthologs12 (Extended Data Fig. 6). We suspect that the missing 
NTD and the use of a denaturing detergent like fos-choline to extract and purify protein from 
inclusion bodies in the NMR study contributed to the discrepancy.
Luminal soluble domains
The NTD and CCD constitute the luminal soluble domains of NfMCU. Despite the poor 
sequence conservation of the NTD among MCU orthologs12 (Extended Data Fig. 6), the 
structures of the NTDs from NfMCU and human MCU are strikingly similar14,15. 
Consisting of seven beta stands (β1-7) and two helices (α1 and 2), each NTD forms a barrel 
enclosed by the 7-stranded β sheet and the α1 helix with the α2 helix sitting atop the barrel 
(Extended Data Fig. 7b). Four NTDs form a well-packed tetrameric ring in a dimer of dimer 
configuration with two-fold symmetry (Fig. 2a). Inter-subunit interactions are defined by 
two types of interfaces. Interface I involves primarily hydrogen bonding between main chain 
atoms on β5 of one subunit and β3 of a neighboring subunit (Fig. 2b) while interface II is 
stabilized by hydrogen bonding between polar side chains (Fig. 2c). A similar dimerization 
at interface I is also observed in the crystal structure of HsMCUNTD (Extended Data Fig. 
7c), thus highlighting the structural conservation of NfMCU to human MCU. The tetrameric 
assembly of the NTD implies its role in maintaining the channel’s architectural integrity. 
However, its functional importance is not entirely clear based on studies of human MCU14,16 
and, thus, warrants further studies.
The CCD consists of four helices labeled as CC1, α3, CC2 and α4 (Fig. 1d and Extended 
Data Fig. 6). The first coiled-coil (CC1) forms an exceptionally long alpha helix that curves 
with respect to the central axis as it extends from the NTD toward the TMD – transitioning 
seamlessly into TM1. A juxtamembrane loop (JML) – approximately 10 residues – and the 
α3 helix connect the end of TM2 to the second coiled-coil (CC2) in two distinct 
conformations between two neighboring subunits (Fig. 1d). In one subunit, the loop runs 
parallel to the membrane and the α3 helix runs almost parallel to CC1, while in the other 
subunit the loop extends nearly perpendicularly from the membrane and the α3 helix 
becomes more perpendicular to CC1. The CC2 helix runs nearly parallel to CC1 to form a 
coiled-coil and the CCD ends with the short α4 helix that runs perpendicularly to the coiled-
coil, jutting away from the central axis (Fig. 1d).
Ion-conducting pore
The NfMCU pore is architecturally unique as compared to classical 2-TM tetrameric cation 
channels like KcsA21, whose outer TM1 helix wraps around the inner pore forming TM2 
helix, generating an inverted teepee-shaped ion conduction pore. Pillared by four TM1s, the 
transmembrane helices of NfMCU enclose a cone-shaped ion conduction pore with wider 
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opening at the luminal side (Fig. 3 and 4a). Interestingly, the pore forming TM2 makes very 
little contact with the TM1 from the same subunit but rather extensively with a neighboring 
TM1 (Fig. 3a). Consequently, there is a wide gap between TM1 and TM2 within each 
subunit at the luminal half of the membrane, which we expect to be sealed by lipid.
NfMCU also lacks the canonical re-entrant pore loop and helix that defines the selectivity 
filter of tetrameric cation channels; instead, the filter residues constitute the first helical turn 
of TM2. The conserved acidic residues of the DIME motif, which is 369DTME372 in 
NfMCU, point toward the central axis and are separated by about one helical turn (Fig. 4). 
Four D369 residues encircle the cytosolic pore entrance of NfMCU with a diagonal distance 
of ~8.0 Å between carboxylate oxygen atoms. The side chains of E372 form the narrowest 
part of the filter with the narrowest opposing carboxylate oxygens measuring about 4.5 Å 
(Fig. 4b). As NfMCU was maintained in 1mM CaCl2 throughout sample preparation, we 
also observed a strong electron density at the center of the E372 ring, which we assigned as 
a Ca2+ chelated by two opposing E372s in a bidentate manner with ion-ligand distances 
between 2.2 – 2.5 Å, optimal for Ca2+ coordination (Fig. 4c, d). The protein packing around 
the filter region also provides insights into the evolutionary conservation of several residues 
within the proximity of the DIME motif. W368 intercalates between TM2 of each subunit 
with its indole ring oriented nearly vertically; its phenyl ring forms CH/π interactions with 
the highly conserved P373 in a stacked-like configuration22,23 while the amino group of the 
pyrrole ring forms intra- and intermolecular hydrogen bonds with the carboxylate oxygen of 
E372 (Fig. 4c, d). Replacing W368 or P373 with alanine resulted in non-functional channels 
(Fig. 4e). Thus, the region constituting the selectivity filter of NfMCU is tightly packed and 
conformationally rigid.
Beyond the selectivity filter, the pore opens into a large, mainly hydrophobic cavity that 
widens toward the base of the ion conduction pathway rather than constrict as seen among 
canonical tetrameric cation channels (Fig. 4a). Whether gating occurs within the ion 
conducting pore is unclear and warrants further studies. However, our in vitro 45Ca2+ flux 
assay and bacteria Ca2+ uptake assay seem to suggest that NfMCU functions as a 
constitutively open channel since the only conditions required to stimulate Ca2+ uptake is an 
electrochemical gradient. Our speculation is also supported by the general consensus that 
Ca2+ activation of the human uniporter is mediated by MICU1 and MICU2 rather the 
channel itself24–27.
Ca2+ permeation and inhibitor binding
The proximity of the two rings of acidic residues – D369s and E372s – within the selectivity 
filter of NfMCU suggests a two-site, single file pore for selective Ca2+ permeation in MCU, 
which is conceptually similar to the classical ion conduction model for voltage-gated Ca2+ 
channel (Cav) 28,29. With a larger diameter, the ring of D369s at the cytosolic entrance 
encircles a low affinity Ca2+ site (site 1) for hydrated ion. The site is likely non-specific, but 
preferable for Ca2+ given the highly negative charge of the ring. The narrow ring consisting 
of E372s forms the high affinity, Ca2+ selective site (site 2) with the acidic side chains 
directly chelating Ca2+, analogous to the high affinity Ca2+ site formed by the EEEE locus 
of CaV channels30. Also, the structural constraint of E372 forces the carboxylate side chains 
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to be near each other – making an empty site 2 energetically unfavorable due to electrostatic 
repulsion. To mitigate this effect, we suspect that site 2 is constitutively bound to Ca2+ with 
high affinity, which can be accomplished at physiological condition given that MCU has 
high affinity for Ca2+ (≤2nM)3. Thus, a potential mechanism for Ca2+ transport in MCU 
likely follows a similar model proposed for CaV channels (Fig. 5a): Ca2+ constitutively 
binds to site 2 under physiological condition and blocks the permeation of Na+ or K+. With 
increasing cytosolic Ca2+ concentration, Ca2+ gradually occupies site 1 and, thereby, provide 
the necessary electrostatic repulsion between sites 1 and 2 to lower the affinity of the site 2 
Ca2+, allowing it to be readily knocked off and move into the water filled vestibule directly 
below the filter. This Ca2+ permeation cycle repeats as the Ca2+ from site 1 hops to site 2 
freeing site 1 to bind a new Ca2+. The presence of the low affinity site external to the high 
affinity site may also explain the inward rectification of Ca2+ permeation observed in MCU.
The two-site model implies that the high affinity site 2 is essential for Ca2+ selectivity while 
the low affinity site 1 is less specific but necessary for efficient Ca2+ permeation. The roles 
of the acidic residues at both sites for Ca2+ permeation were tested in NfMCU using our 
bacteria uptake assay. We first examined the effect of neutralizing the two acidic residues 
individually (D369N and E372Q). Consistent with observations in human MCU4,16, the 
E372Q mutant no longer conducts Ca2+ while the D369N mutant exhibited a slight 
reduction in Ca2+ uptake (Fig. 5b and Extended Data Fig. 8). We also asked whether 
disrupting the ion coordination distance had any effect on channel function. Interestingly, a 
D369E mutation showed ~50% greater Ca2+ uptake rate compared to the WT while the 
E372D mutant remained nonfunctional. A similar D261E mutation in human MCU – the 
equivalent mutation as D369E for NfMCU – showed a slight reduction in calcium uptake16. 
Mutating D369 to threonine or glutamine yielded nonfunctional channels. These data 
confirm that site 2 (E372), which is essential for specific Ca2+ binding, is highly sensitive to 
mutations whereas the non-specific site 1 (D369) is more tolerable to mutations.
The structure of NfMCU also offers a unique opportunity to probe the mechanism of Ru360 
binding. In human MCU, a serine (S259) two residues preceding the DIME motif was 
initially identified to be important for Ru360 binding4, since an alanine mutant conferred 
resistance to the drug while still allowing calcium transport. In NfMCU, the equivalent 
residue is a glycine. Studies on cMCU-ΔNTD identified the aspartate of the DIME motif as 
a second key residue for Ru360 binding31, which we suspect is the primary Ru360 binding 
site for NfMCU since the DIME motif is conserved across all MCU orthologs. Neutralizing 
the aspartate (D369N) weakened Ru360 blocking while maintaining the charge but reducing 
the pore diameter at site 1 (D369E) eliminated Ru360 blocking (Fig. 5c, d). This result 
confirms that D369 in NfMCU forms the primary blocking site for Ru360, whose binding is 
dictated by the charge as well as the pore size at site 1.
Conclusion
Thus, the structure of NfMCU provides the first model of an intact mitochondrial calcium 
uniporter determined to near atomic resolution, shedding new insights into channel assembly 
and function. Contrary to the structure of cMCU-ΔNTD, NfMCU functions as a tetrameric 
calcium channel, whose pore is poised for rapid ion conduction. In essence, the channel 
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provides a rather finite barrier measuring ~6 Å – the distance separating the filter aspartate 
and glutamate – that Ca2+ must traverse from the intermembrane space to the matrix. The 
combination of having two ion binding sites and a huge electrochemical gradient across the 
inner mitochondrial membrane provide the necessary driving force for MCU to selectively 
conduct Ca2+. It is notable that early studies of calcium transport demonstrated that 
mitochondria from diverse eukaryotes have uniporter activity11. However, the kinetics and 
apparent binding affinities of calcium uptake by fungal mitochondria are appreciably 
different from that of vertebrate11. While NfMCU reveals the architectural arrangement of 
the basic channel component of the uniporter, further study is needed to address some 
fundamental questions about metazoan uniporter function, such as how metazoan MCU 
evolved to require EMRE for ion conduction and how MICU1 and MICU2 confer Ca2+-
dependent gating to the uniplex.
Methods
Expression and purification of NfMCU
The construct for NfMCU (NCBI accession number: XP_001266985.1), which was codon 
optimized for expression in E. coli and cloned into the pCOLD II vector32. For functional 
assay, the full-length protein with only the mitochondrial targeting sequence removed (see 
Extended Data Fig. 5) was modified to contain an N-terminal 6x-His tag and a thrombin 
cleavage site (LVPRGS) and then reinserted back into the pCOLD II vector (Takara) using 
the restriction sites NdeI/XhoI. For structural studies, the NfMCU construct used in the 
function assay was further truncated by an additional 10 residues each from the N- and C-
termini and then cloned into the pCOLD II vector using the same restriction sites. Although 
no significant functional difference was observed between the full-length protein and the 
truncated channel (Extended Data Fig. 1b), the truncated construct yields a significantly 
more monodispersed profile on gel filtration and was subsequently used for structural 
studies (Extended Data Fig. 1a). All single-site mutants were generated using the 
Quikchange Site-Directed Mutagenesis Kit (Agilent) and confirmed by DNA sequencing.
E. coli (BL21 DE3) were freshly transformed, plated onto LB/ampicillin (LB/Amp) agar, 
and grown overnight. Colonies were harvested directly from LB/Amp plates to seed LB 
media (100μg/mL ampicillin) and grown in shaker flasks at 37°C in an orbital shaker until 
the cells reached an OD600 = 0.37–0.4, at which point they were transferred to another 
orbital shaker pre-chilled to 15°C and allowed to grow for another hour before protein 
expression was induced by addition of IPTG to a final concentration of 0.4mM. Cells were 
then grown at 15°C for 16–18 hours before being harvested. The cell pellets were flash 
frozen in liquid nitrogen and stored at −80°C.
To purify NfMCU, the cell pellets were resuspended in lysis buffer (50mM Tris pH 8, 
300mM NaCl, 1mM CaCl2), supplemented with protease inhibitors (1 μg/mL each of DNase 
I, pepstatin, leupeptin and aprotinin, and 1 mM PMSF), and then homogenized on ice. To 
remove inclusion bodies and misfolded protein, the homogenate was centrifuged at 10,000 × 
g for 20 minutes at 4°C. The supernatant was harvested and NfMCU was extracted with 1% 
(w:v) n-dodecyl-β-D-maltopyranoside (DDM, Anatrace) by gentle agitation for 1 hour on 
ice. After extraction, the supernatant was collected following a 30-minute centrifugation at 
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21,000 × g at 4°C and then incubated with Ni-NTA resin (Qiagen) with gentle agitation on 
ice for 1 hour. The resin was collected on a disposable gravity column (Bio-Rad), washed 
with wash buffer A (lysis buffer + 1mM DDM) for 3 column volumes and then with wash 
buffer B (lysis buffer + 1mM DDM + 30mM imidazole) for 10 column volumes. NfMCU 
was eluted with wash buffer C (lysis buffer + 1mM DDM + 300 mM imidazole). Thrombin 
was added at a ratio of 1 unit of thrombin per 1L culture of bacterial cell pellet; the sample 
was allowed to incubate at 20°C, overnight, to remove the His-tag. NfMCU is then 
concentrated and further purified by size exclusion chromatography on a Superdex 200 
10/300 GL column (GE Heathcare) pre-equilibrated with buffer D (20mM HEPES pH 7.5, 
300mM NaCl, 1mM CaCl2, 1mM DDM). The main peak (eluting around 11mL) was then 
collected for further biochemical and structural analysis.
Reconstitution of NfMCU into saposin
We were unsuccessful in reconstituting NfMCU following the original protocol20, likely due 
to the recommended step of heat shocking the sample during reconstitution. We thus made 
some modifications to the protocol, which we believe is better suited for more sensitive or 
less stable membrane proteins. Our reaction consists of the following components mixed at a 
molar ratio of 1:3:10 (NfMCU : saposin : E. coli total lipids). As a substitution for the 
recommended heat-shock step20, saposin was destabilized by incubation with sodium 
cholate (15mM final concentration) with rotation at 4 °C for 1 hour. Purified NfMCU 
(concentrated to 100μM) was then added to the reaction and allowed to rotate at 4°C for 1 
hour before addition of BioBeads (BioRad) to remove detergents. The reaction was 
incubated with BioBeads for 3–4 hours at 4°C, and BioBeads exchange was performed a 
total of 3 times with each incubation step lasting 3–4 hours at 4°C. The reconstituted 
NfMCU saposin complex was separated from empty saposin complex and aggregates by gel 
filtration chromatography on a Superdex 200 10/300 GL column (GE Heathcare) pre-
equilibrated with buffer E (20mM HEPES pH 7.5, 300mM NaCl, 1mM CaCl2, 2% glycerol). 
The main peak (eluting around 11mL) was then collected for structural analysis.
EM data acquisition
Prior to freezing grids, the NfMCU saposin complex (concentrated to 0.6mg/mL) was 
incubated with 50μM Ru360 on ice for 30 minutes. The cryo-EM grids were prepared by 
applying 3 μL of the NfMCU-saposin-Ru360 complex to a glow-discharged Quantifoil 
R1.2/1.3 300-mesh gold holey carbon grid (Quantifoil, Micro Tools GmbH, Germany) and 
blotted for 4.0 seconds under 100% humidity at 4 °C before being plunged into liquid ethane 
using a Mark IV Vitrobot (FEI). Micrographs were acquired on a Titan Krios microscope 
(FEI) operated at 300 kV with a K2 Summit direct electron detector (Gatan), using a slit 
width of 20 eV on a GIF-Quantum energy filter as well as a Volta phase plate following the 
same approach for phase plate data collection as previously described33. EPU software (FEI) 
was used for automated data collection following standard FEI procedure. A calibrated 
magnification of 59,523X was used for imaging, yielding a pixel size of 0.84 Å on images. 
The defocus was set at −0.5 μm. Each micrograph was dose-fractionated to 30 frames under 
a dose rate of 4 e−/pixel/s, with a total exposure time of 12 s, resulting in a total dose of 
about 60 e−/Å2.
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Image processing
For the NfMCU phase plate dataset, motion correction was performed using the 
MotionCorr2 program34, and the CTF parameters of the micrographs were estimated using 
the GCTF program35. All other steps of image processing were performed using RELION36. 
Initially, about 1,000 particles were manually picked from a few micrographs. Class 
averages representing projections of NfMCU in different orientations were selected from the 
2D classification of the manually picked particles, and used as templates for automated 
particle picking from the full data set of 2,470 micrographs. The 526,554 extracted particles 
were binned 3 times and subjected to two rounds of 2D classification, and a total of 355,929 
particles were finally selected for 3D classification using the initial model generated by 
RELION as the reference. Two of the 3D classes showed good secondary structural features 
and their particles were selected, combined and re-extracted into the original pixel size of 
0.84 Å. After 3D refinement with C2 symmetry imposed and particle polishing, the resulting 
3D reconstructions from 128,231 particles yielded an EM-map with a resolution of 3.8 Å. 
The transmembrane domain showed poor density, indicating a local structural heterogeneity. 
Therefore, we performed a focused 3D classification with density subtraction in order to 
improve the density of the transmembrane domain37. In this approach, the density 
corresponding to the soluble domains of the channel as well as the belt-like density from 
saposin was subtracted from the original particles. The subsequent 3D classification on the 
modified particles was carried out by applying a mask around the transmembrane domain 
and having all the orientations fixed at the value determined in the initial 3D refinement. 
After this round of classification, one class (83,343 particles) with better density in the 
transmembrane domain was selected for 3D refinement, yielding an EM map of 3.8 Å in 
which the entire transmembrane domain can be modeled. All resolutions were estimated by 
applying a soft mask around the protein density and the gold-standard Fourier shell 
correlation (FSC) = 0.143 criterion. ResMap38 was used to calculate the local resolution 
map.
Model building, refinement, and validation
De novo atomic model building was conducted in Coot39. Since the crystal structure of the 
NTD of human MCU14 (PDB: 4XTB) fits nicely in the EM map, it was used as a guide to 
build the NTD of NfMCU. Amino acid assignment was achieved based on the clearly 
defined density for bulky residues (Phe, Trp, Tyr, and Arg). Models were refined against 
summed maps using phenix.real_space_refine40, with secondary structure restraints applied. 
The model was validated using previously described methods to avoid overfitting41,42. The 
3.8 Å EM density map of NfMCU allowed us to construct a model containing the following 
residues: chain A, B: 124–200, 258–399, and 406–461; chain C, D: 124–196, 259–396, and 
404–461. Although we added Ru360 in our sample with the hope of seeing how it blocks the 
channel pore, its density was not visible in the structure. One main reason could be the 
symmetry mismatch. As the MCU pore entrance has 4-fold symmetry, Ru360 could bind to 
the pore in four different orientations, causing its density to be averaged out. The statistics 
for the model’s geometries were generated using MolProbity43. Pore radii were calculated 
using the HOLE program44. All the figures were prepared in PyMol45 or Chimera46.
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Bacterial calcium uptake assay
E. coli expressing NfMCU were grown as described above with the exception that protein 
induction was allowed to proceed for 16 hours, at which time the cells were harvested, 
centrifuged at 4000 × g for 10 minutes at 4°C, and the media was discarded. To remove 
residual media, the cell pellet was resuspended in ice-cold buffer (50mM HEPES pH 7.4, 
150mM KCl) and then centrifuged again (4000 × g for 10 minutes at 4°C) and the 
supernatant was discarded. To prepare the bacteria for calcium uptake measurements, the 
bacteria were treated as though they were mitochondria and prepared as previously 
described for the purification of mitochondria from yeast47 but with slight modifications. To 
remove residual Ca2+, the cells were resuspended to a final concentration of 10mg/mL in 
ice-cold bacteria prep buffer (0.6M D-mannitol, 10mM KH2PO4, 20mM HEPES pH 7.4, 
5mg/mL bovine serum albumin) plus 1mM EDTA and allowed to shake gently on ice for 30 
minutes. To replenish any Mg2+ that was chelated by EDTA treatment, 2mM MgCl2 was 
then added into the cell resuspension followed by gentle shaking on ice for another 30 
minutes. The cells were then centrifuged (4000 × g for 10 minutes at 4°C) and the 
supernatant was discarded. The cells were centrifuged again (4000 × g for 3 minutes at 4°C) 
and residual buffer was removed with a pipette. The wet weight of the bacteria was 
measured with a digital balance (typical yield is ~80mg of bacteria per 30mL culture of 
bacteria). The cells were then resuspended in ice-cold reaction buffer (0.6M D-mannitol, 
20mM HEPES pH 6.8, 10μM EGTA, 0.5mg/mL bovine serum albumin) to a final 
concentration of 10mg/mL and were used immediately for calcium uptake measurement.
To measure calcium uptake, we relied on the highly negative membrane potential across the 
plasma membrane of E. coli48 and used the fluorescent calcium indicator Oregon Green 
BAPTA-6F (Life Technologies), which was added to a final concentration of 1μM (from 
aliquots of a 500μM stock kept at −20°C) to cells resuspended in reaction buffer, to monitor 
the Ca2+ concentration changes over time using fluorescence signal – a conventional 
approach for monitoring mitochondrial calcium uptake in the field4,5. For calcium uptake 
measurements, 100μL of cell suspension was added to a 96-well plate (Corning) and 
fluorescence was monitored in a Molecular Devices SpectraMax M3 plate reader (excitation/
emission: 485nm/535nm). Baseline fluorescence was measured for all samples at the start of 
each reaction for 60 seconds followed by addition of 5μL CaCl2 stock to the 100μL reaction 
in any experiment to reach the desired concentration. With the exception of the experiment 
in Figure 1A, where the bacteria were pulsed 3 times with 20μM CaCl2, all measurements 
were from samples pulsed only once with the concentration of CaCl2 indicated in the figure 
legend. Fluorescence was monitored for 4 minutes to assess calcium uptake.
For the inhibition experiments (either with GdCl3 or Ru360), the inhibitor was added to 
1000μL of cell suspension to the highest desired concentration of inhibitor for the 
experiment and this cell suspension was then used as a stock to dilute into a cell suspension 
without any inhibitor added (to a final volume of 100μL) to obtain a series of cells in the 
desired inhibitor concentration. The samples were then pulsed with 50μM CaCl2 and 
fluorescence was monitored for 4 minutes.
To ensure protein expression was comparable among the NfMCU mutants tested in our 
uptake assay, Western blot analysis was performed on each sample used for each 
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experiment. Extended Data Figure 8 shows representative Western blots of an experimental 
trial using the NfMCU mutants referred to in this study. Mouse anti-His antibodies (Qiagen) 
was used to detect NfMCU expression and mouse anti-E. coli RNA polymerase alpha or 
anti-RpoA (Santa Cruz Biotechnology) was used as a loading control. HRP-conjugated 
sheep anti-mouse antibodies were used as the secondary antibodies (GE Healthcare).
All data were analyzed in GraphPad Prism 7 (GraphPad Software, Inc.). To obtain the rate of 
calcium uptake, the linear phase of the uptake measurement – the first 45–60 seconds of the 
reaction following CaCl2 administration – was determined by fitting the data to a linear 
regression equation in GraphPad Prism; the slope of the fit is taken as the rate of calcium 
uptake. Further analysis such as normalization are indicated in the figure legend. To obtain 
the IC50 for Ru360, the relative calcium uptake rates were fitted to a dose-response curve in 
GraphPad Prism.
Radioactive 45Ca flux assay
In light of the contradiction of the oligomeric state between NfMCU and cMCU-ΔNTD, we 
designed an in vitro functional assay by reconstituting our purified tetrameric channel into 
liposomes. Unable to obtain currents of NfMCU by electrophysiology – probably due to the 
channel’s small conductance – we performed a radioactive 45Ca flux assay on 
proteoliposomes loaded with 150mM KCl.
NfMCU was reconstituted into lipid vesicles using a similar protocol as described49. E. coli 
total lipid (Avanti) was prepared following standard protocol and then solubilized in dialysis 
buffer (50mM HEPES pH 7.4, 150mM KCl) supplemented with 40mM n-decyl-β-D-
maltopyranoside (DM, Anatrace). Purified NfMCU in DDM (at ~1mg/mL) was mixed with 
the DM-solubilized E. coli total lipid at a ratio of 1:100 (w:w, protein:lipids). NfMCU and 
lipid mixture were incubated with gentle rotation at 4°C for 1 hour and then dialyzed (using 
dialysis tubing with a molecular weight cutoff of 12,000–14,000 Da, Spectra/Por) against 1L 
of dialysis buffer at 4°C to remove detergent. Fresh dialysis buffer (1L each time) was 
exchanged every 18–20 hours for a total of 3 exchanges. Following dialysis, NfMCU 
proteoliposomes were divided into 100μL aliquots, flash frozen in liquid nitrogen, and stored 
at −80°C. For all flux assays, three separate batches of bacteria were grown to express 
NfMCU. The protein was then purified individually and used immediately for reconstitution 
into liposomes.
The 45Ca flux assay was performed following the same procedures as previously described 
but with slight modifications49. NfMCU proteoliposomes were thawed and sonicated in a 
bath sonicator for 60 seconds at 15 second intervals before the assay. 100 μL samples were 
passed through a pre-spun Sephadex G-50 fine gel filtration column (1.5 mL bed volume in 
a 5 mL disposable spin column) swollen in flux buffer (50 mM HEPES pH 7.4, 150mM KCl 
or NMDG). The resulting 160 μL of proteoliposome eluent was collected and added to 300 
μL of reaction buffer (flux buffer + 0.2μM valinomycin + 83μM 45CaCl2) to initiate the 
reaction. At various time points, 75 μL of this reaction mixture was passed through a pre-
spun Sephadex G-50 fine gel filtration column as previously described to remove extra-
liposomal 45Ca and stop the flux. The eluent was mixed with 10 mL scintillation cocktail 
and its radioactivity was measured in a scintillation counter.
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For the Ru360 inhibition experiments, NfMCU proteoliposomes in flux buffer (50 mM 
HEPES pH 7.4, 150mM NMDG) were mixed with reaction buffer containing varying 
concentrations of Ru360 (dissolved in NMDG flux buffer + 0.2μM valinomycin + 83μM 
45CaCl2). The reaction was allowed to proceed for 30 minutes, after which the reaction was 
stopped by passing 75μL of the reaction through a pre-spun Sephadex G-50 fine gel 
filtration column as previously described. To determine the relative calcium uptake by 
NfMCU proteoliposomes, the scintillation count for each sample was normalized to the 
sample without any Ru360 in the reaction.
Data availability
The cryo-EM density maps of the NfMCU have been deposited in the Electron Microscopy 
Data Bank under accession numbers EMD-7826 (without saposin) and EMD-7828 (with 
saposin, low-pass filter to 5.0 Å resolution). Atomic coordinates have been deposited in the 
Protein Data Bank under accession numbers 6D7W (without saposin) and 6D80 (with 
saposin modeled as poly-A peptide). Source data for Fig. 4e, Fig 5b–d, Extended Data Fig. 
1b and Extended Data Fig. 2 are available in Supplementary Information. The gel source 
data for Fig. 4e, Extended Data Fig. 1b and 1c, and Extended Data Fig. 8 are available in 
Supplementary Figure 1.
Extended Data
Extended Data Figure 1. Biochemical analysis of NfMCU
a, Representative gel filtration profile of full-length (black trace) versus truncated NfMCU 
used for cryo-EM studies (blue trace). b, Functional activity of full-length (FL) and 
truncated NfMCU (EM); data shown represent mean ± SEM (n=3 independent experiments). 
Cell lysates were analyzed by immunoblotting using anti-His antibody to detect expression 
of NfMCU; RpoA was used as loading control. c, Detergent solubilized NfMCU (control) 
separates as a single band at ~46 kDa on Coomassie stained SDS-PAGE and crosslinks as 
tetramers when treated with chemical crosslinkers of varying spacer arm length. (DSG: 
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disuccinimidyl glutarate, DSS: disuccinimidyl suberate, BS3: bis(sulfosuccinimidyl) 
suberate, BSPEG5: PEGylated bis(sulfosuccinimidyl)suberate). See Supplementary Figure 1 
for gel source data. The experiments shown in a and b were repeated at least three times 
independently with similar results. The crosslinking experiment shown in c was performed 
once.
Extended Data Figure 2. Functional characterization of NfMCU
a, Calcium uptake in E. coli expressing empty vector (black trace) or NfMCU (blue trace), 
demonstrating that the heterologously expressed NfMCU can confer uniporter function to 
bacteria. Arrows indicate addition of 20μM CaCl2 to the reaction solution. b, Concentration 
dependent calcium uptake in E. coli expressing empty vector (black trace) or NfMCU (blue 
trace). Each point represents the rate of calcium uptake normalized to the uptake rate at 
90μM CaCl2. c, Concentration dependent inhibition of NfMCU by GdCl3 in E. coli 
expressing NfMCU. Each point represents the rate of calcium uptake normalized to the 
uptake rate without GdCl3 in the reaction. d, Concentration dependent inhibition of Ca2+ 
uptake in E. coli expressing NfMCU by the MCU-specific inhibitor Ru360. Each point 
represents the rate of calcium uptake normalized to the uptake rate without Ru360 in the 
reaction. The Ru360 concentration required to reduce the Ca2+ uptake rate by half (or IC50) 
is calculated to be 0.5μM. e, In light of the contradiction of the oligomeric state between 
NfMCU and cMCU-ΔNTD, we also designed an in vitro functional assay by reconstituting 
our purified tetrameric channel into liposomes. Unable to obtain currents of NfMCU by 
electrophysiology – probably due to the channel’s small conductance – we performed a 
radioactive 45Ca flux assay on proteoliposomes loaded with 150 mM KCl. Shown here is the 
time-dependent 45Ca2+ uptake by empty liposomes or NfMCU proteoliposomes incubated 
with 45Ca2+ in a reaction buffer containing 150mM KCl (red points) or 150mM NMDG 
(blue points). The result demonstrates that in a reaction solution containing 150mM NMDG 
and the K+-selective ionophore valinomycin (to generate an electrical driving force), 
NfMCU proteoliposomes exhibited time-dependent 45Ca uptake while the same 
proteoliposomes in a reaction solution containing valinomycin and 150mM KCl (to 
eliminate electrical driving force) accumulated 45Ca2+ only slightly better than empty 
liposomes, recapitulating the voltage-dependent Ca2+ uptake property of the MCU. f, 
Concentration dependent inhibition of NfMCU proteoliposomes by Ru360, demonstrating 
that Ru360 also blocks NfMCU 45Ca2+ uptake in a concentration-dependent manner up to 
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50%, which is expected given an equal distribution of two channel orientations in the 
liposomes. Each point represents radioactivity measured following 30 min reaction 
normalized to sample without Ru360. All data points shown in a–f are mean ± SEM (n=3 
independent experiments).
Extended Data Figure 3. Cryo-EM analysis of NfMCU
a, Representative phase-plate electron micrograph of the NfMCU saposin complex and 2470 
micrographs were used for structure determination. b, Representative 2D class averages of 
the NfMCU saposin complex. c, Flowchart of data processing to obtain the 3.8 Å cryo-EM 
map of the NfMCU saposin complex. Details can be found in the “Image processing” 
section of the Methods. d, Local resolution of NfMCU estimated with RELION2.0. e, FSC 
curves for the refined model versus the summed 3.8 Å map (black curve), the refined model 
versus half map 1 (red curve), and the refined model versus half map 2 that was not used for 
refinement (green curve). f, The gold-standard Fourier shell correlation curve for the cryo-
EM map.
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Extended Data Figure 4. EM map of NfMCU
a, Representative regions of the EM map of NfMCU highlighting key structural features at 
the NTD (a1, a2, b2–b3), the coiled-coil domain, and transmembrane domain (TM1 and 
TM2). Protomer 1 and 2 are shown in yellow and orange, respectively. b, Stereo view of the 
EM map carved around the TM2 filter region of NfMCU.
Extended Data Figure 5. Cryo-EM structure of NfMCU in complex with saposin
a, Cryo-EM map of NfMCU in complex with saposin (shown alternating between purple 
and pink). The map is low-pass filtered to 5 Å to allow for better visualization of the density 
from the saposin molecules. Six saposin molecules, each oriented at a 45° angle to the 
vertical axis, wrap around NfMCU stabilized in lipid. b, Ribbon diagram of NfMCU in 
complex with saposin. Approximately 79–81 residues of the 81-residue saposin molecule 
was modeled as a poly-alanine chain into the helix-turn-helix EM map density for saposin.
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Extended Data Figure 6. Sequence alignment of MCU orthologs
The sequences were aligned using PROMALS3D50 and numbered according to NfMCU. 
Secondary structures shown above the sequences are based on the cryo-EM structure of 
NfMCU. Loops are denoted by solid black lines; disordered regions not observed in the 
cryo-EM structure of NfMCU are indicated by dashed lines; and truncations made to 
NfMCU at the N- and C-termini are shown as red rectangles. The first 75 residues in 
NfMCU (colored purple) are predicted to be the mitochondrial targeting sequence (MTS). 
NCBI accession number for the sequences are: [HsMCU (human MCU): NP_612366.1, 
MmMCU (mouse MCU): XP_006513531.1, DdMCU (Dictyostelium discoideum MCU): 
XP_637750.1, CeMCU (C. elegans MCU): NP_500892.1, NcMCU (Neurospora crassa 
MCU): XP_959658.1, NfMCU (Neosartorya fischeri MCU): XP_001266985.1].
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Extended Data Figure 7. Structure comparison between MCU domains
a, Overall structure comparison between tetrameric NfMCU and pentameric cMCU-ΔNTD 
(PDB: 5ID3). Each subunit is individually colored. b, Structure comparison between a single 
subunit of the pore domain of NfMCU and cMCU-ΔNTD. Dashed boxes indicate major 
differences between the two structures. Structural features in cMCU-ΔNTD are labeled as in 
the original structure16. (IJMH: inner juxtamembrane helix, OJMH: outer juxtamembrane 
helix, L1: loop 1, L2: loop 2, JML: juxtamembrane loop, CC1: coiled-coil 1, CC2: coiled 
coil 2). c, Structure comparison between the NTD of NfMCU and HsMCU (PDB: 4XTB). 
Dashed box indicates the major difference between the two structures. d, Atomic 
interactions between two NTD subunits in the crystal structure of HsMCU NTD, equivalent 
to interface I identified in the cryo-EM structure of NfMCU.
Extended Data Figure 8. Western blot analysis of NfMCU expression in E. coli
NfMCU, with its mitochondrial targeting sequence removed and replaced with a 6x-His tag, 
was expressed in E. coli for functional analysis. Mouse anti-His antibodies (Qiagen) was 
used to detect NfMCU expression and mouse anti-RpoA targeting E. coli RNA polymerase 
alpha (Santa Cruz Biotechnology) was used for loading control. See Supplementary Figure 1 
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for gel source data. The experiment was repeated three times independently with similar 
results.
Extended Data Table 1
Cryo-EM data collection and model statistics
NfMCU NfMCU saposin complex
(EMDB-7826) (PDB 6D7W) (EMDB-7828) (PDB 6D80)
Data collection and processing
Magnification 59,523 59,523
Voltage (kV) 300 300
Electron exposure (e−/Å2) 60 60
Defocus range (μm) −0.5 −0.5
Pixel size (Å) 0.84 0.84
Symmetry imposed C2 C2
Initial particle images (no.) 526,554 526,554
Final particle images (no.) 128,231 128,231
Map resolution (Å) 3.8 5.0
 FSC threshold 0.143 0.143
Map resolution range (Å) 184.8–3.8 184.8–5.0
Refinement
Initial model used (PDB code) Initial model generated in RELION2.0 Initial model generated in RELION2.0
Model resolution (Å) 3.8 5.0
 FSC threshold 0.143 0.143
Model resolution range (Å) 184.8–3.8 184.8–5.0
Map sharpening B factor (Å2) −120 −120
Model composition
 Non-hydrogen atoms 8,946 11,351
 Protein residues 1,087 1,568
 Ligands 1
B factors (Å2) 103.55 135.43
 Protein 103.55 135.43
 Ligand 127.22 127.22
R.m.s. deviations
 Bond lengths (Å) 0.008 0.007
 Bond angles (°) 1.396 1.306
Validation
 MolProbity score 2.41 2.33
 Clashscore 14 13
 Poor rotamers (%) 0.9 0.9
Ramachandran plot
 Favored (%) 93 93
 Allowed (%) 7 7
 Disallowed (%) 0 0
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Cryo-EM structure of NfMCU
a, The overall cryo-EM map of NfMCU with density for saposin removed for clarity. b, 
Overall architecture of NfMCU colored by subunit and divided into major structural 
domains. c, Each NfMCU tetramer assembles as a dimer of dimer. Each dimer consists of 
two protomers adopting distinct conformations. d, Structural comparison of the two 
protomers in each MCU dimer. Dashed circles highlight the distinct conformation of the 
juxtamembrane loop (JML) in the two protomers.
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Figure 2. Channel assembly and subunit interfaces at the NTD
a, Top view of surface rendered NfMCU showing inter-subunit interactions at the NTD. b, 
Detailed view of atomic interactions at interface I in NfMCU consisting of hydrogen bonds 
mainly between main chain atoms. c, Atomic interactions at interface II consist of mainly 
side chain hydrogen bonds.
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Figure 3. Channel assembly and subunit interfaces at the TMD
a, Surface rendered model of NfMCU with zoomed-in view of the inter-subunit interactions 
at the TMD between TM2 of one subunit and TM1 of a neighboring subunit. b, Top view of 
NfMCU at the pore entrance and exit, highlighting the unique arrangement of the TM 
helices in channel assembly and the widening of the pore moving down the ion conduction 
pathway.
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Figure 4. Ion conduction pore of NfMCU
a, Ribbon diagram of the NfMCU pore domain with the ion conduction pathway rendered as 
gray mesh and one pair of the acidic filter residues (D369 and E372) shown as sticks. b, 
Pore radius along the central axis. c, Side view of the selectivity filter region with the front 
subunit removed for clarity, highlighting the arrangement of the DIME motif and the 
approximate cross distance measurements between D369 residues and Ca2+ coordination 
distances for E372 (shown as dashed lines). d, Top view of the selectivity filter region. E372 
forms a hydrogen bond network with W368. Ca2+ (green sphere) is coordinated by a pair of 
E372 in a bidentate manner. Dashed circle marks the inter-subunit packing between W368 
and P373. e, Functional activity of NfMCU W368 and P373 mutants expressed in E. coli. 
Data points are mean ± SEM (n=3 independent experiments). Protein expression level was 
analyzed by immunoblotting using E. coli RNA polymerase alpha (RpoA) as control 
(Methods). The experiment was repeated three times independently with similar results.
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Figure 5. Mechanism of ion transport and Ru360 inhibition
a, Proposed model of calcium permeation in NfMCU. b, Concentration dependent calcium 
uptake in E. coli expressing NfMCU filter mutantions. Data are normalized to the calcium 
uptake rate of wild-type NfMCU at 90μM CaCl2. c, Normalized concentration dependent 
Ru360 inhibition of E. coli expressing NfMCU D369N. d, Representative calcium uptake 
trace for E. coli expressing NfMCU D369E mutant with or without Ru360. Arrow indicates 
addition of 50μM CaCl2 to the reaction. Bar graph shows the rate of calcium uptake 
normalized to the uptake rate without Ru360 in the reaction. All data points shown in b–c 
are mean ± SEM (n=3 independent experiments).
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